Last reviewed · How we verify

NCT06223464

Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix

Status unknown Last updated 25 January 2024
What this trial tests

trial in Adenomyosis in 130 participants. Status unknown.

Timeline
18 October 2023
Primary endpoint
18 December 2023
18 April 2024

Quick facts

Lead sponsorAnkara Etlik City Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment130
Start date18 October 2023
Primary completion18 December 2023
Estimated completion18 April 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Ankara Etlik City Hospital

Who can join

Adults 18 to 45, female only, with Adenomyosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the potential of cervical elastography, a non-invasive method, in the accurate diagnosis and clinical course of adenomyosis. Cervical elastography is an imaging method that measures the elasticity properties of cervical tissue using ultrasound technology. This method may be helpful in providing information about the development and clinical course of adenomyosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adenomyosis

Currently open trials in the same condition.

Other Ankara Etlik City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing